IDEXX Laboratories Inc (IDXX)
429.01
+5.59
(+1.32%)
USD |
NASDAQ |
Nov 07, 14:24
IDEXX Laboratories Net Income (Quarterly): 232.84M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 232.84M |
| June 30, 2024 | 203.30M |
| March 31, 2024 | 235.58M |
| December 31, 2023 | 194.52M |
| September 30, 2023 | 212.23M |
| June 30, 2023 | 224.24M |
| March 31, 2023 | 214.05M |
| December 31, 2022 | 172.21M |
| September 30, 2022 | 180.94M |
| June 30, 2022 | 131.98M |
| March 31, 2022 | 193.96M |
| December 31, 2021 | 162.77M |
| September 30, 2021 | 175.24M |
| June 30, 2021 | 202.58M |
| March 31, 2021 | 204.26M |
| December 31, 2020 | 174.79M |
| September 30, 2020 | 146.22M |
| June 30, 2020 | 148.94M |
| March 31, 2020 | 111.83M |
| December 31, 2019 | 90.50M |
| September 30, 2019 | 108.84M |
| June 30, 2019 | 125.71M |
| March 31, 2019 | 102.68M |
| December 31, 2018 | 85.64M |
| September 30, 2018 | 93.25M |
| Date | Value |
|---|---|
| June 30, 2018 | 108.69M |
| March 31, 2018 | 89.45M |
| December 31, 2017 | 38.26M |
| September 30, 2017 | 70.51M |
| June 30, 2017 | 85.36M |
| March 31, 2017 | 69.02M |
| December 31, 2016 | 52.37M |
| September 30, 2016 | 56.46M |
| June 30, 2016 | 67.20M |
| March 31, 2016 | 46.02M |
| December 31, 2015 | 44.35M |
| September 30, 2015 | 44.22M |
| June 30, 2015 | 56.91M |
| March 31, 2015 | 46.59M |
| December 31, 2014 | 25.96M |
| September 30, 2014 | 52.14M |
| June 30, 2014 | 57.22M |
| March 31, 2014 | 46.58M |
| December 31, 2013 | 43.26M |
| September 30, 2013 | 45.69M |
| June 30, 2013 | 54.00M |
| March 31, 2013 | 44.86M |
| December 31, 2012 | 43.35M |
| September 30, 2012 | 42.85M |
| June 30, 2012 | 51.32M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
90.50M
Minimum
Dec 2019
235.58M
Maximum
Mar 2024
180.65M
Average
187.45M
Median
Net Income (Quarterly) Benchmarks
| Baxter International Inc | -314.00M |
| Agilent Technologies Inc | 282.00M |
| Bio-Rad Laboratories Inc | 653.17M |
| West Pharmaceutical Services Inc | 136.00M |
| NovaBay Pharmaceuticals Inc | -1.585M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 975.54M |
| Total Expenses (Quarterly) | 671.65M |
| EPS Diluted (Quarterly) | 2.80 |
| Enterprise Value | 35.24B |
| Gross Profit Margin (Quarterly) | 61.10% |
| Profit Margin (Quarterly) | 23.87% |
| Earnings Yield | 2.42% |
| Operating Earnings Yield | 3.10% |
| Normalized Earnings Yield | 2.417 |